Vimarsana
Biggest News Aggregation in the World

Page 47 - Roche Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roche Group Today - Breaking & Trending Today

Lineage to Present at 2023 International Spinal Research Trust Network Meeting - Vimarsana News

Lineage to Present at 2023 International Spinal Research Trust Network Meeting

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that Gary S. Hogge, D.V.M., M.S., Ph.D.,...

FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | Region - Vimarsana News

FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | Region

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--

FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | National Business - Vimarsana News

FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | National Business

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--

FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | Business - Vimarsana News

FDA Accepts Application for Genentech's Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition | Business

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sep 6, 2023--

Curis to Present at Upcoming Healthcare Conferences in September - Vimarsana News

Curis to Present at Upcoming Healthcare Conferences in September

LEXINGTON, Mass., Sept. 6, 2023 /PRNewswire/ -- Curis, Inc. , a biotechnology company focused on the development of emavusertib, an orally available small molecule IRAK4 inhibitor for the treatment...